CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Our results showed that the total number of colonies (colony-forming unit—granulocyte/macrophage (CFU-GM) + colony-forming unit—erythroid (CFU-E) + burst forming unit—erythroid (BFU-E)) significantly decreased in CML CD34+-treated cells with 100 nM Meds433 (Fig. 4E, left panel).